
    
      A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Single & Multiple
      Ascending Dose Study to Access the Tolerability and Pharmacokinetics of Kangdaprevir Sodium
      Tablet in Healthy Adult Subjects.
    
  